On March 13, 2018, Oregon Governor Kate Brown signed a bill that requires drugmakers to report research and development and marketing costs, along with profits and more, for drugs that get price hikes of more than 10%. Companies will also be required to report whether generics are available. The Oregon bill (HB 4005) is the most recent state-level drug pricing transparency law that attempts to control the cost of prescription drugs and is quite similar to the California legislation that is the subject of a legal challenge. However, HB 4005 goes a step further than that California legislation and seems …
avril, 2018
mars, 2018
-
7 mars
Loi anti-cadeaux et transparence : qu’en est-il pour les chirurgiens-dentistes ?
Laure le Calvé, avocat au Barreau de Paris, associée du cabinet LCH (Law Compliance Health), conseille les industriels du monde de la santé et intervient régulièrement sur les questions liées aux relations entre les industries et les professionnels de santé. Le dispositif de la loi anti-cadeaux a bientôt 25 ans. Au cours de ces 25 années, il a été complété par celui de la loi « transparence », et modifié récemment par l’Ordonnance n°2017-49 du 19 janvier 2017. Trois sociétés commercialisant du matériel dentaire ont été poursuivies pour avoir proposé et procuré, de manière directe, ou indirecte à des chirurgiens-dentistes, …
-
7 mars
Undisclosed conflicts of interest among biomedical textbook authors
Textbooks are a formative resource for health care providers during their education and are also an enduring reference for pathophysiology and treatment. Unlike the primary literature and clinical guidelines, biomedical textbook authors do not typically disclose potential financial conflicts of interest (pCoIs). The objective of this study was to evaluate whether the authors of textbooks used in the training of physicians, pharmacists, and dentists had appreciable undisclosed pCoIs in the form of patents or compensation received from pharmaceutical or biotechnology companies Authors were listed as inventors on 677 patents (maximum/author = 23), with three-quarters (74.9%) to HarPIM authors. Females were …
-
5 mars
MAROC : Bientôt une loi “anti-bakchich” entre laboratoires pharmaceutiques et professionnels de santé?
Une proposition de loi pour plus de transparence et moins de collusions d’intérêts entre l’industrie pharmaceutique et les professionnels du secteur est portée par le groupe PJD à la Chambre des représentants. Elle prévoit des plafonds pour les cadeaux et des sanctions à la clé. “Il y a des dérapages dans les relations entre d’un côté certains laboratoires pharmaceutiques, fabricants de produits esthétiques et de dispositifs médicaux, et de l’autre, certains professionnels de santé, associations de malades et médias”, assène Mustapha Brahimi, député PJD, membre de la commission des secteurs sociaux à la Chambre des représentants. Si le phénomène est …
février, 2018
-
26 février
The biopharmaceutical’s stock took a tumble after the Wall Street Journal asserted that the company has been breaking the Sunshine Act
Shares of MiMedx Group (NASDAQ:MDXG), a biopharmaceutical company focused on regenerative medicine, were down 11% as of 3:15 p.m. EST on Friday. The drop was spurred by an article published on Thursday stating that the company had failed to make legally required reports of payments that it made to doctors. The article published by The Wall Street Journal stated that MiMedx had not disclosed its financial relationships with more than 20 doctors — a failure to comply with the Physician Payments Sunshine Act, which was passed in 2013. To read the article by Brian Feroldi
-
23 février
Ontario law to require drug firms to reveal funds paid to doctors’ groups, patient advocates
Right now, Canadian patient-advocacy groups can disclose as much or as little as they like about the donations they receive from drug or device makers. Some make detailed disclosures on their websites; most do little more than putting the names or logos of their industry sponsors online. In draft regulations posted on Wednesday, February 21, 2018, the Ontario government laid out how the health-sector transparency law it passed last year will work, including listing the 31 categories of funding recipients who will be covered by the new disclosure system, the first of its kind in Canada. These changes will allow anyone …
